Janux Therapeutics
Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient’s healthy tissue. Janux technology targets all three stages of the anti-tumor immune response.
Domain
januxrx.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$350.0M
Founded
2016
Tech Stack (25 technologies)
Frequently Asked Questions
What technologies does Janux Therapeutics use?+
Janux Therapeutics uses 25 technologies including Divi, Font Awesome, Google Analytics.
What industry is Janux Therapeutics in?+
Janux Therapeutics operates in the Biotechnology industry.
Where is Janux Therapeutics based?+
Janux Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026